Busulphan and cyclophosphamide for pretransplant conditioning
Shaw, P.J.; Stevens, M.M.
Bone Marrow Transplantation 3(4): 367
1988
ISSN/ISBN: 0268-3369 PMID: 3048500 Document Number: 321187
Document emailed within 1 workday
Related Documents
Vellodi, A.; Jurges, E.; el-Tumi, M.; Abdul-Ahad, A.; Hobbs, J.R. 1991: Bone marrow transplantation from unrelated donors for genetic diseases following conditioning with Busulphan and Cyclophosphamide Bone Marrow Transplantation 7(Suppl 2): 70Russell, S.; Vowels, M. 1992: Busulphan, cyclophosphamide, and melphalan as conditioning therapy in allogeneic bone marrow transplants for acute lymphoblastic leukemia Transplantation Proceedings 24(1): 183
Angelucci, E.; Polchi, P.; Lucarelli, G.; Galimberti, M.; Baronciani, D.; Giardini, C.; Durazzi, S.M.; Moretti, L.; Donati, M. 1989: Allogeneic bone marrow transplantation for hematological malignancies following therapy with high doses of busulphan and cyclophosphamide Haematologica 74(5): 455-461
Hobbs, J.R.; Hugh-Jones, K.; Shaw, P.J.; Downie, C.J.; Williamson, S. 1986: Engraftment rates related to busulphan and cyclophosphamide dosages for displacement bone marrow transplants in fifty children Bone Marrow Transplantation 1(2): 201-208
Porcellini, A.; Manna, A.; Moretti, L.; Carotenuto, M.; Greco, M.M.; Bodenizza, C. 1989: Busulfan and cyclophosphamide as conditioning regimen for autologous BMT in acute lymphoblastic leukemia Bone Marrow Transplantation 4(3): 331-333
Shepherd, J.D.; Hoar, D.I.; Keown, P.A.; Phillips, G.L. 1996: Successful paternity of twins following bone marrow transplantation with busulfan, melphalan and cyclophosphamide conditioning Bone Marrow Transplantation 17(3): 461-462
Lee, J.H.; Lee, J.H.; Lee, J.S.; Kim, W.K.; Chi, H.S.; Lee, K.H. 2001: Cyclophosphamide and antithymocyte globulin conditioning may be sufficient for Korean patients with early stage severe aplastic anemia transplanted with marrow from donors other than HLA-identical siblings Haematologica 86(4): 434-435
Nagatoshi, Y.; Okamura, J.; Ikuno, Y.; Akamatsu, M.; Tasaka, H. 1997: Therapeutic trial of intensified conditioning regimen with high-dose cytosine arabinoside, cyclophosphamide and either total body irradiation or busulfan followed by allogeneic bone marrow transplantation for myelodysplastic syndrome in children International Journal of Hematology 65(3): 269-275
Vasta, S.; Scimé, R.; Indovina, A.; Majolino, I. 1992: CNS toxicity and high-dose busulphan in three patients undergoing bone marrow transplantation Haematologica 77(2): 189
Trouillas, P.; Neuschwander, P.; Nighoghossian, N.; Adeleine, P.; Tremisi, P. 1989: Intensive immunosuppression in progressive multiple sclerosis. An open study comparing 3 groups: cyclophosphamide, cyclophosphamide-plasmapheresis and control subjects. Results after 3 years Revue Neurologique (Paris) 145(5): 369-377
Tajima, A.; Aso, Y.; Suzuki, K.; Ohtawara, Y.; Ohta, N.; Hata, M.; Ushiyama, T.; Nakano, M.; Yaguchi, Y. 1989: Lymphocytapheresis as pretransplant immunosuppression Transplantation Proceedings 21(1 Part 2): 1722-1725
Thorsby, E.; Ettenger, R.; Garovoy, M. 1984: Pretransplant immunologic considerations Transplantation Proceedings 16(6): 1649-1653
West, R.J.; Zweig, S.F. 1997: Meta-analysis of chemotherapy regimens for ovarian carcinoma: a reassessment of cisplatin, cyclophosphamide and doxorubicin versus cisplatin and cyclophosphamide European Journal of Gynaecological Oncology 18(5): 343-348
MacLeod, A.M.; Mason, R.J.; Power, D.A.; Edward, N.; Stewart, K.N.; Shewan, G.; Catto, G.R. 1983: Pretransplant antibodies and renal allograft survival Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 20: 305-308
Jardine, I.; Fenselau, C.; Appler, M.; Kan, M.N.; Brundrett, R.B.; Colvin, M. 1978: Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy Cancer Research 38(2): 408-415
Dyk, T.; Piotrowski, M.; Kostecka, W. 1973: Acute hemopericardium due to acute thrombocytopenia developing during Busulphan treatment of polycythemia vera Polski Tygodnik Lekarski 28(7): 259-260
Held, P.J.; Agodoa, L.Y.; Wolfe, R.A.; Port, F.K.; Garcia, J.R. 1989: The role of pretransplant time and therapy on kidney graft survival Clinical Transplants 1989: 55-62
Abendroth, D.; Schilling, M.; Fenzlein, P.G.; Land, W. 1993: Pretransplant assessment of renal viability by using ion-selective electrodes--a pilot study Transplantation Proceedings 25(4): 2563-2564
Valderrábano, F.; Anaya, F.; Pérez-García, R.; Olivas, E.; Vasconez, F.; Jofre, R. 1983: Transfusion-induced anergy: skin test as an index for pretransplant transfusions Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 20: 338-348
Sumimoto, R.; Lindell, S.; Gambiez, L.; Southard, J.H.; Belzer, F.O. 1993: Effect of pretransplant flushout of the liver with a solution containing albumin on survival and organ function Transplantation Proceedings 25(6): 3001-3003